Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Rheumatology"
DOI: 10.1080/03009742.2021.2003033
Abstract: Objective The optimal choice of a second biological disease-modifying anti-rheumatic drug (bDMARD) after failure with first line tumour necrosis factor inhibitor (TNFi) represents a critical therapeutic challenge. This study aims to evaluate the persistence with… read more here.
Keywords: persistence; rheumatology; first line; line ... See more keywords
Impact of residential area on the management of rheumatoid arthritis patients initiating their first biologic DMARD
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000015517
Abstract: Abstract Access to care and management of Rheumatoid Arthritis (RA) patients may differ based on residential area. We described differences in the profile of patients initiating their first biologic disease modifying antirheumatic drug (bDMARD) based… read more here.
Keywords: residential area; area; management rheumatoid; initiating first ... See more keywords
FRI0129 Comparative safety of biologic dmard initiation in ra: a population-based observational study of malignancy risk
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2887
Abstract: Background Patients (pts) with RA are at increased risk for some malignancies and the use of biologic (b)DMARDs has been reported to further increase this risk.1 Abatacept (ABA), the first selective T-cell co-stimulation modulator for… read more here.
Keywords: risk; initiation; treatment; bdmard ... See more keywords
SAT0108 CHARACTERISTICS OF MULTIRESISTANT PATIENTS TO BIOLOGICAL TREATMENTS IN RHEUMATOID ARTHRITIS, AND ASSOCIATED FACTORS : AN OBSERVATIONAL AND RETROSPECTIVE STUDY IN 385 PATIENTS
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.1646
Abstract: Background Despite a wide range of biological treatments (bDMARDs) in the management of rheumatoid arthritis (RA), some patients fail in different lines of treatment. Currently, there is no consensual definition of multiresistance to bDMARDs in… read more here.
Keywords: biological treatments; characteristics multiresistant; study; rheumatoid arthritis ... See more keywords